Oppenheimer Starts Benitec BioPharma (BNTC) at Outperform
Tweet
Share
E-mailGet Alerts BNTC Hot Sheet
Price: $12.56 --0%
Rating Summary:
9 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
9 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Oppenheimer initiates coverage on Benitec BioPharma (NASDAQ: BNTC) with a Outperform rating and a price target of $35.00.
For an analyst ratings summary and ratings history on Benitec BioPharma click here. For more ratings news on Benitec BioPharma click here.
Shares of Benitec BioPharma closed at $10.16 yesterday.
You May Also Be Interested In
- ICICI Securities Resumes Oberoi Realty Ltd (OBER:IN) at Buy (1)
- Raymond James Starts SpyGlass Pharma (SGP) at Outperform
- Raymond James Starts Polaryx Therapeutics (PLYX) at Strong Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
